Showing results (181-190 of 235) with videos related to

Sort By:
Pageof 24
Nature Medicine|July 8, 1999
Protective effects of C5a blockade in sepsisB J Czermak, V Sarma, C L Pierson, et al.
Clinical Nutrition (Edinburgh, Scotland)|July 18, 2024
Effect of a comprehensive lifestyle intervention program on body weight and health behavior in women with breast cancer: Results from a randomized controlled trialDagmar Hauner, Julia Günther, Florian Schederecker, et al.
Oncology Research and Treatment|February 25, 2025
Will Minimal Residual Disease Monitoring Be Part of Routine Surveillance?Kerstin Pfister, Henning Schäffler, Sophia Huesmann, et al.
Breast Cancer Research and Treatment|March 23, 2019
Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trialRafael J A Cámara, Lukas Schwentner, Thomas W P Friedl, et al.
British Journal of Cancer|April 1, 2016
Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR studyW Janni, N Harbeck, B Rack, et al.
Breast Cancer Research and Treatment|May 13, 2015
Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancerChristoph Scholz, U Andergassen, P Hepp, et al.
The American Journal of Pathology|June 1, 1997
Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activationK S Kilgore, E Schmid, T P Shanley, et al.
The American Journal of Pathology|October 20, 1998
Differing patterns of P-selectin expression in lung injuryN M Bless, S J Tojo, H Kawarai, et al.
American Journal of Respiratory Cell and Molecular Biology|October 6, 1997
Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharideB Beck-Schimmer, R C Schimmer, R L Warner, et al.
Clinical Breast Cancer|August 18, 2020
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From the Multi-Center Randomized ADEBAR TrialInga Bekes, Martin Eichler, Susanne Singer, et al.
Pageof 24